Protheragen Launches Comprehensive Impurity Research Solutions to Strengthen Drug Safety and Regulatory Compliance
New York, United States, April 22, 2026 — Protheragen, an ISO9001 certified supplier of pharmaceutical ingredients and specialty chemicals, announces its expanded suite of end-to-end impurity solutions covering impurity synthesis & isolation, forced degradation impurity… Read More »Protheragen Launches Comprehensive Impurity Research Solutions to Strengthen Drug Safety and Regulatory Compliance





